1. Home
  2. LFST vs EVO Comparison

LFST vs EVO Comparison

Compare LFST & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LifeStance Health Group Inc.

LFST

LifeStance Health Group Inc.

HOLD

Current Price

$6.25

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.38

Market Cap

895.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LFST
EVO
Founded
2015
1993
Country
United States
Germany
Employees
N/A
4766
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
895.8M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
LFST
EVO
Price
$6.25
$2.38
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
1
Target Price
$9.71
$7.00
AVG Volume (30 Days)
2.2M
110.9K
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,424,285,000.00
N/A
Revenue This Year
$17.18
N/A
Revenue Next Year
$14.02
$7.13
P/E Ratio
N/A
N/A
Revenue Growth
13.85
N/A
52 Week Low
$3.74
$2.31
52 Week High
$8.09
$4.80

Technical Indicators

Market Signals
Indicator
LFST
EVO
Relative Strength Index (RSI) 37.72 32.84
Support Level $6.16 $2.31
Resistance Level $6.63 $3.75
Average True Range (ATR) 0.20 0.08
MACD -0.01 0.02
Stochastic Oscillator 8.49 21.76

Price Performance

Historical Comparison
LFST
EVO

About LFST LifeStance Health Group Inc.

LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: